Skip to main content
logo
Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
2.280
-0.120 (-5.00%)
At close: Aug 26, 2026, 4:00 PM EDT
2.340
+0.060 (2.63%)
After-hours: Aug 26, 2026, 5:24 PM EDT

Aethlon Medical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-6.94-7.15-13.39-12.21-12.03-10.42
Depreciation & Amortization
0.320.320.340.360.240.12
Loss (Gain) From Sale of Assets
---0.020.14-
Stock-Based Compensation
0.260.280.421.221.050.75
Other Operating Activities
0.290.294.8900.020.03
Change in Accounts Receivable
----0.130.02
Change in Accounts Payable
-0.87-0.38-0.050.16-0.170.1
Change in Unearned Revenue
-----0.340.23
Change in Other Net Operating Assets
-0.24-0.360.150.320.46-0.6
Operating Cash Flow
-7.18-7-7.65-10.13-10.51-9.77
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-0.01-0--0.25-0.94-0.35
Investing Cash Flow
-0.01-0--0.25-0.94-0.35

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Issuance of Common Stock
9.657.759.081.328.9317.46
Repurchase of Common Stock
-0.01-0.01-0.02-0.03-0.01-0.09
Other Financing Activities
-1.3-1.22-1.33---
Financing Cash Flow
8.346.527.731.298.9117.37

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.020.01-0.010-0.01-
Net Cash Flow
1.17-0.470.07-9.09-2.547.25

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-7.19-7-7.65-10.38-11.45-10.12
Free Cash Flow Growth
------
Free Cash Flow Margin
-----1993.62%-3439.01%
Free Cash Flow Per Share
-32.61-51.95-244.92---
Levered Free Cash Flow
-4.79-4.54-4.89-6.49-7.02-6.22
Unlevered Free Cash Flow
-4.78-4.53-4.88-6.49-7.02-6.22

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Change in Working Capital
-1.11-0.740.090.480.07-0.25
SEC Filings: 10-K · 10-Q